Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease

International Urology and Nephrology

Volumn 47, Issue 7, 2015, Pages 1173-1180

  Bondor, Cosmina Ioana ^a   Potra, Alina Ramona ^a   Moldovan, Diana ^a   Rusu, Crina Claudia ^a   Ciorba Pop, Mariana ^a   Muresan, Adriana ^a   Vladutiu, Dan Stefan ^a   Kacso, Ina Maria ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Adiponectin; Diabetes; Malondialdehyde; Nephropathy; Oxidative stress; Superoxide dismutase

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ADIPOQ PROTEIN, HUMAN;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; ROMANIA;

ADIPONECTIN; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROMANIA; SUPEROXIDE DISMUTASE;

EID: 84933181007     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-1004-2     Document Type: Article

References (38)

1. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188
2. Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442–2450
3. Hopkins TA, Ouchi N, Shibata R, Walsh K (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11–18
4. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D (2005) Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20:129–134
5. Komaba H, Igaki N, Goto S, Yokota K, Doi H, Takemoto t et al (2006) Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26:476–482
6. Sweiss N, Sharma K (2014) Adiponectin effects on the kidney. Best Pract Res Clin Endocrinol Metab 28:71–79
7. Christou GA, Kiortsis DN (2014) The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 221:49–61
8. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K et al (2007) Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 27:1910–1917
9. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR et al (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Investig 118:1645–1656
10. Lin J, Hu FB, Curhan G (2007) Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 30:239–244
11. Kacso IM, Bondor CI, Kacso G (2012) Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients. Scand J Clin Lab Investig 72:333–339
12. Sharma K (2011) Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl 4:113–117
13. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Investig 114:1752–1761
14. Cui R, Gao M, Qu S, Liu D (2014) Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance. Gene Ther 21:840–848
15. Tavafi M (2013) Diabetic nephropathy and antioxidants. J Nephropathol 2:20–27
16. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 16:461–470
18. Pippenger CE, Browne RW, Armstrong D (1993) Regulatory antioxidant enzymes. In: Armstrong D (ed) Methods in molecular biology, vol 108: free radicals and antioxidant protocols, 1st edn. Humana Press, Totowa, pp 299–311
19. Diaconu R, Macarie A, Orasan R (2014) Analysis of oxidative stress in sun-exposed and unexposed skin. Int J Bioflux Soc 6:153–157
20. Sankhla M, Sharma TK, Mathur K, Rathor JS, Butolia V, Gadhok AK et al (2012) Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome. Clin Lab 58:385–392
21. El-Mesallamy HO, Hamdy NM, Salman TM, Mahmoud S (2011) Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s). Minerva Endocrinol 36:163–170
22. Vatansever E, Surmen-Gur E, Ursavas A, Karadag M (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15:275–282
23. Takahashi R, Imamura A, Yoshikane M, Suzuki M, Cheng XW, Numaguchi Y et al (2009) Circulating malondialdehyde-modified low-density lipoprotein is strongly associated with very small low-density lipoprotein cholesterol concentrations in healthy men. Clin Chim Acta 399:74–78
24. Wang X, Pu H, Ma C, Jiang T, Wei Q, Zhang C et al (2014) Adiponectin abates atherosclerosis by reducing oxidative stress. Med Sci Monit 20:1792–1800
25. Song W, Huo T, Guo F, Wang H, Wei H, Yang Q et al (2013) Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. Neuroscience 248:136–144
26. Yao R, Zhou Y, He Y, Jiang Y, Liu P, Ye L et al (2015) Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress. Exp Ther Med 9:131–136
27. Hou N, Huang N, Han F, Zhao J, Liu X, Sun X (2014) Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats. Int Urol Nephrol 46:2045–2051
28. Choi R, Kim BH, Naowaboot J, Lee MY, Hyun MR, Cho EJ et al (2011) Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp Mol Med 43(676–6):83
29. Kim HJ, Vaziri ND, Norris K, An WS, Quiroz Y, Rodriguez-Iturbe B (2010) High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol 14:536–547
30. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS et al (2007) Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology 12:391–398
31. Lim PS, Chen SL, Wu MY, Hu CY, Wu TK (2007) Association of plasma adiponectin levels with oxidative stress in hemodialysis patients. Blood Purif 25:362–369
32. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S (2004) Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 181:413–417
33. Li X, Li MR, Guo ZX (2012) Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose. Chin Med J 125:4209–4213
34. Fukushima J, Kamada Y, Matsumoto H, Yoshida Y, Ezaki H, Takemura T et al (2009) Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatol Res 39:724–738
35. Chetboun M, Abitbol G, Rozenberg K, Rozenfeld H, Deutsch A, Sampson SR et al (2012) Maintenance of redox state and pancreatic beta-cell function: role of leptin and adiponectin. J Cell Biochem 113:1966–1976
36. Krautbauer S, Eisinger K, Lupke M, Wanninger J, Ruemmele P, Hader Y et al (2013) Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. Exp Mol Pathol 95:330–335
37. Bauer S, Wanninger J, Neumeier M, Wurm S, Weigert J, Kopp A et al (2011) Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients. Exp Mol Pathol 90:101–106
38. Zeng L, Tang WJ, Yin JJ, Zhou BJ (2014) Signal transductions and nonalcoholic fatty liver: a mini-review. Int J Clin Exp Med 7:1624–1631